The administration of THC significantly reduces lung tumor size and lesions, according to preclinical data presented this week at the annual meeting of the American Association for Cancer Research (AACR) in Los Angeles.So what do you think a plant extract might do to the market for anti-cancer drugs like Erbitux (Cetuximab) and Vectibix (Panitumumab)?
Investigators at Harvard University's Division of Experimental Medicine reported that THC inhibited the growth and spread of cells in vitro from two different lung cancer cell lines and from patient lung tumors. They also reported that THC administration reduced the growth of lung tumors in mice by more than 50 percent compared to untreated controls over a three-week period.
Researchers noted that THC appeared to block a specific cancer-causing protein in a manner similar to the pharmaceutical anti-cancer drugs Erbitux (Cetuximab) and Vectibix (Panitumumab).
Results of a large-scale, case-controlled population study published last year found that smoking cannabis, even long-term, is not positively associated with increased incidence of lung-cancer. Investigators in that study noted that one subset of moderate lifetime users had an inverse association between cannabis use and lung cancer, leading them to speculate that cannabinoids may possess certain protective properties against the development of lung cancer in humans.
I will let you draw your own conclusions about why the pharmaceutical companies are the biggest supporters of the Drug Free America Campaign.
Special to Astute Bloggers' readers:
For over thirty years the Drug War has suppressed research into the beneficial uses of banned drugs. Fortunately, thanks to efforts of researchers like Israel's Dr. Raphael Mechoulam and America's Rick Doblin those embargoes are being broken.
Cross Posted at Power and Control and at Classical Values